DataMeds AI, Inc. reported second quarter 2026 financial results and provided a business update on August 17, 2026. Revenues grew 14% sequentially to $1.779 million, beating management projections, while the company recorded a net loss of $18.363 million compared to $6.672 million in the prior year period. The increased loss was driven by debt extinguishment expenses and general administrative costs. Key developments include a $6.5 million new funding round completed in June 2026, restructuring of $14.5 million in pre-existing debt, and the implementation of a 1-for-50 reverse stock split in May 2026 to address Nasdaq delisting risks. The company also announced lock-up agreements for approximately 49% of outstanding shares and plans to launch the 'Health Lives Here' consumer app with NFL Alumni Health in September 2026. DataMeds AI, Inc. operates in the healthcare technology industry, leveraging artificial intelligence and blockchain platforms to provide integrated healthcare solutions and data monetization services.
